By your side for a healthier world™

Items in my cart

Loading your cart..

The West Blog

Subscribe to receive the latest blog post

Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.

View Post

Lynn Yao

Manager, Scientific Affairs, CN

Particles Injectable Drug Products Packaging

{1}

{2}

{3}

{4}

Previous Posts

Ready Pack System

December 04, 2020

How to get your biologic approved quickly when you don’t have the resources of big pharma

Abbey Hisler

Director, Segment Marketing, Biologics

Biologics Drug Development Whitepapers

Integrated Solutions Program Graph

September 11, 2020

Introducing West’s New Interactive Integrated Solutions Webpage

Shari Krusniak

Director, Marketing, Contract Manufacturing & Integrated Solutions

Customer Experience Drug Development Integrated Solutions Knowledge Center

SmartDose in use.

August 14, 2020

How the FDA PFDD initiative is bringing the patients voice earlier into drug development

Victoria Morgan

Global Director, Segment Marketing

SmartDose Drug Delivery Platform Drug Development Market Traction

May 08, 2020

Daikyo Crystal Zenith® Cyclic Olefin Polymer – the Right Polymer for Drug Product Packaging

Page McAndrew, PhD.

Director, Scientific Communications

Daikyo Crystal Zenith Cyclic Olefin Polymer Polymer Drug Product Packaging

Compounding Pharmacy drug products

May 01, 2020

Injectable Combination Product Development: Facilitating Risk-Based Assessments for Efficiency and Patient Centric Outcomes

Fran DeGrazio

Chief Scientific Officer, Strategy & Science Integration

Combination Product Drug Development

Revision

April 13, 2020

Revised Drug Administration Law of the People’s Republic of China

Lynn Yao

Manager, Scientific Affairs, China

Revised Regulations China Laws Drug Administration

AFM topography and modulus mapping image

April 10, 2020

Not All Barriers Are Created Equal

Cathy Zhao

Director, Scientific Insights Lab

Barriers Coatings Importance of Barriers drug packaging systems

Analytical Labs

April 03, 2020

Generic Drugs in China – Understanding the Regulatory Landscape

Lynn Yao

Manager, Scientific Affairs, China

Generic Drugs China Regulations Regulatory Landscape

Daikyo Crystal Zenith Syringe and vial and stoppers and seals

March 16, 2020

Simplify the Journey™ – Selecting Compatible Container and Delivery Systems for Protein/mAb Drugs

Ranjana Singh

Sr. Scientist, Insight Labs

Drug compatibility Drug delivery system Delivery of Drugs

A Team collaborating in a meeting

January 14, 2020

The Latest on Regulations: ICH Guideline to Manage Change throughout the Commercial Lifecycle of Drugs and Combination Products – Part 1

Fran DeGrazio

VP, Scientific Affairs & Technical Services

Regulations ICH Guidelines Lifecycle Drugs Combination Products

By Your Side for Innovation

October 23, 2019

West Addresses Injectable Drug Delivery Challenges with Innovative Product Offerings and Services

Karen Flynn

Sr. VP & Chief Commercial Officer

Injectable Drug Delivery Product Innovation Products Services

Elastomers, Stoppers and Plungers

May 14, 2019

Industry Trends in China: The Generic Consistency Evaluation

Lynn Yao

Manager, Scientific Affairs, CN

Components Compliance Industry trends Generic Drug Products

Load more